FdaApplication
BLA 761497
Identifiers
- fda_app_no: BLA761497
Properties
| Property | Value |
|---|---|
| applicant_name | Emerge Bioscience Pte. Ltd. |
| application_type | BLA |
| approval_date | 2026-07-24 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| GARZULYS | INSULIN ASPART-FSAN | 300UNITS/3ML (100UNITS/ML) | VIAL;MULTIDOSE |
| GARZULYS | INSULIN ASPART-FSAN | 1,000UNITS/10ML (100UNITS/ML) | Injection |
2 products